Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$7.79 - $16.29 $123,339 - $257,919
15,833 New
15,833 $164,000
Q1 2021

May 14, 2021

SELL
$86.23 - $125.19 $603 - $876
-7 Closed
0 $0
Q3 2020

Nov 12, 2020

SELL
$81.91 - $134.94 $573 - $944
-7 Reduced 50.0%
7 $1,000
Q2 2020

Aug 14, 2020

BUY
$54.33 - $89.52 $760 - $1,253
14 New
14 $2,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $463M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Pathstone Family Office, LLC Portfolio

Follow Pathstone Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Family Office, LLC with notifications on news.